Compare StocksEMR vs PFE

Emerson Electric Co. (EMR) vs Pfizer Inc. (PFE)

EMR
Emerson Electric Co.
$137.45
VS
PFE
Pfizer Inc.
$26.33

Rewards

EMR
  • Altman Z-Score of 4.10 indicates very low bankruptcy risk — the company is firmly in the safe zone.
PFE
  • Gross margin of 75.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Dividend yield of 6.53% with a consistent or growing payout over the past 4 years.
  • FCF yield of 9.0% is historically attractive — the business generates significant cash relative to its price.

Risks

EMR
  • Trailing P/E of 33.7x is 49% above the historical average of 22.6x — the stock trades at a premium to its own history.
  • PEG ratio of 6.88 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
PFE
  • ROIC has declined by 13.9 percentage points over the observed period, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
EMR
PFE
Valuation
$2.88B
Free Cash Flow
$13.43B
3.73%
FCF Yield
8.97%
33.69
Trailing P/E
19.36
19.23
Forward P/E
9.36
Quality & Moat
10.29%
ROIC
7.67%
11.30%
ROE
8.96%
52.76%
Gross Margin
75.81%
6.88
PEG Ratio
13.77
Balance Sheet Safety
0.69
Debt / Equity
0.78
N/A
Interest Coverage
N/A
2.09
Net Debt / EBITDA
2.10
1.62%
Dividend Yield
6.53%
EMR: 4Ties: 2PFE: 6
EMRPFE

Historical Fundamentals

Learn more →
EMR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

$1 Retained Earnings Test

Learn more →
EMR
$1.29
created per $1 retained over 3 years
Value Creator
Σ Retained
$13.89B
Δ Market Cap
+$17.88B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EMR
74.5% Overvalued
Price is 74.5% above estimated fair value
Current Price: $137.45
Fair Value: $78.78
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
130.7% Overvalued
Price is 130.7% above estimated fair value
Current Price: $26.33
Fair Value: $11.41
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EMR

What growth rate is the market pricing in at $137?

+16.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.7%

The market implies +16.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.7%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $26?

+11.4%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.0%

The market implies +11.4% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EMR
61/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
EMR
-2.75
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EMR
Insiders 0.2%Institutions 83.9%Retail & Other 15.8%
No. of Institutional Holders2,766
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 67.9%Retail & Other 32.0%
No. of Institutional Holders3,687
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EMR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EMR
3
Sells (3M)
5
Sells (12M)
Total value (12M): $6.09M
LEVATICH MATTHEW S
Director
$239,349
@ $162.16 · 2026-02-10
PIAZZA NICHOLAS J
Officer
$1.07M
@ $159.07 · 2026-02-09
BLINN MARK A
Director
$438,930
@ $152.62 · 2026-02-05
KARSANBHAI SURENDRALAL LANCA
Chief Executive Officer
$965,979
@ $133.00 · 2025-12-03
TRAIN MICHAEL H
Officer
$3.38M
@ $119.44 · 2025-05-12
BLINN MARK A
Director
$2,505
@ $125.25 · 2025-02-12
LEVATICH MATTHEW S
Director
$233,472
@ $125.05 · 2025-02-12
BLINN MARK A
Director
$234,701
@ $125.71 · 2025-02-10
TRAIN MICHAEL H
Officer
$2.71M
@ $125.96 · 2024-11-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
0
Sells (3M)
0
Sells (12M)
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EMR
FearGreed
😐Neutral(47/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(54/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EMR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (54)
View EMR Full AnalysisView PFE Full Analysis
EMR vs PFE: Which Is the Better Buy? | SafetyMargin.io